A site-specific analysis of the ADP-Ribosylome unveils Homogeneous DNA Damage-Induced Serine ADP-Ribosylation across wild-type and BRCA-mutant Breast Cancer cell lines
Aganho, H.; Mullari, M.; Gyorgy Prosz, A.; Buch-Larsen, S. C.; Locard-Paulet, M.; Szalassi, Z.; Nielsen, M. L.
Show abstract
ADP-ribosylation (ADPr) signaling plays a crucial role in the DNA damage response. Inhibitors against the main enzyme catalyzing ADPr after DNA damage - PARP1 - are used as targeted therapies against breast cancers with BRCA1/2 mutations. However, development of resistance to PARP inhibitors (PARPi) is a major obstacle in treating patients. To better understand the role of ADPr in PARPi sensitivity, we used Liquid Chromatography-Mass Spectrometry (LC-MS) for systems level analysis of the ADP-ribosylome in six breast cancer cell lines exhibiting different PARPi sensitivities. We identified 1,632 sites on 777 proteins across all cell lines, primarily on serine residues, with site-specific overlap of targeted residues across DNA damage-related proteins across all cell lines, demonstrating high conservation of serine ADPr signaling networks upon DNA damage. We furthermore observed site-specific differences in ADPr intensities in PARPi-sensitive BRCA mutants, and unique ADPr sites in PARPi-resistant BRCA mutant cells, which we notably show to have low PARG levels and longer ADPr chains on PARP1.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- System-wide Identification and prioritization of Enzyme Substrates by Thermal Analysis (SIESTA) 96%
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 96%
- High resolution profiling of cell cycle-dependent protein and phosphorylation abundance changes in non-transformed cells 96%
Similar papers in this journal
- PRPS activity tunes redox homeostasis in Myc-driven lymphoma 94%
- Characterization of the Glutathione Redox State in the Golgi Apparatus 94%
- Epidermal Growth Factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium 94%
Similar papers in this journal
Similar papers in this journal
- Spatial proteomics reveals subcellular reorganization in human keratinocytes exposed to UVA light 96%
- Transcriptomic and proteomic regulation through abundant, dynamic, and independent arginine methylation by Type I and Type II PRMTs 95%
- Functional and spatial proteomics profiling reveals intra- and intercellular signaling crosstalk in colorectal cancer 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.